173 related articles for article (PubMed ID: 2455727)
1. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex.
Baxter RC
J Clin Endocrinol Metab; 1988 Aug; 67(2):265-72. PubMed ID: 2455727
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of binding subunits of the human 150K insulin-like growth factor binding protein.
Gelato MC; Gaynes LA; Greenstein LA; Nissley SP
J Clin Endocrinol Metab; 1990 Apr; 70(4):879-87. PubMed ID: 1690749
[TBL] [Abstract][Full Text] [Related]
3. Structure, specificity, and regulation of the insulin-like growth factor-binding proteins in adult rat serum.
Yang YW; Wang JF; Orlowski CC; Nissley SP; Rechler MM
Endocrinology; 1989 Sep; 125(3):1540-55. PubMed ID: 2547590
[TBL] [Abstract][Full Text] [Related]
4. Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I.
Barreca A; Ponzani P; Arvigo M; Giordano G; Minuto F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1318-24. PubMed ID: 7536206
[TBL] [Abstract][Full Text] [Related]
5. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels.
Binoux M; Seurin D; Lassarre C; Gourmelen M
J Clin Endocrinol Metab; 1984 Sep; 59(3):453-62. PubMed ID: 6205015
[TBL] [Abstract][Full Text] [Related]
6. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
Lee CY; Rechler MM
Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum.
Liu F; Baxter RC; Hintz RL
J Clin Endocrinol Metab; 1992 Nov; 75(5):1261-7. PubMed ID: 1385469
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex.
Baxter RC; Dai J
Endocrinology; 1994 Feb; 134(2):848-52. PubMed ID: 7507839
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs.
Martin JL; Baxter RC
Endocrinology; 1988 Oct; 123(4):1907-15. PubMed ID: 2970958
[TBL] [Abstract][Full Text] [Related]
10. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions.
Kanzaki S; Baxter RC; Knutsen R; Baylink DJ; Mohan S
J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph.
Binoux M; Hossenlopp P
J Clin Endocrinol Metab; 1988 Sep; 67(3):509-14. PubMed ID: 2457595
[TBL] [Abstract][Full Text] [Related]
12. Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity.
Baxter RC; Martin JL; Wood MH
J Clin Endocrinol Metab; 1987 Sep; 65(3):423-31. PubMed ID: 2442186
[TBL] [Abstract][Full Text] [Related]
13. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling.
Baxter RC; Martin JL
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):6898-902. PubMed ID: 2476804
[TBL] [Abstract][Full Text] [Related]
14. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum.
Baxter RC; Martin JL; Beniac VA
J Biol Chem; 1989 Jul; 264(20):11843-8. PubMed ID: 2473065
[TBL] [Abstract][Full Text] [Related]
15. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially.
Lee CY; Rechler MM
Endocrinology; 1995 Feb; 136(2):668-78. PubMed ID: 7530649
[TBL] [Abstract][Full Text] [Related]
16. Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium.
Mohan S; Bautista CM; Herring SJ; Linkhart TA; Baylink DJ
Endocrinology; 1990 May; 126(5):2534-42. PubMed ID: 1691698
[TBL] [Abstract][Full Text] [Related]
17. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
[TBL] [Abstract][Full Text] [Related]
18. Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.
Cohen DA; Blethen SL
J Clin Endocrinol Metab; 1983 Mar; 56(3):461-6. PubMed ID: 6185524
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
20. Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol wt growth hormone-dependent complex in human plasma.
Martin JL; Baxter RC
J Clin Endocrinol Metab; 1985 Oct; 61(4):799-801. PubMed ID: 2411755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
